FGF23 and androgen insensitivity syndrome: Therefore, the objective of this study was to assess whether baseline FGF23 levels are associated with the occurrence of major adverse cardiovascular and cerebrovascular events (MACCEs) in AIS patients.<h4>Methods</h4>In this study, 394 patients with AIS were enrolled.